Cytokinetics (CYTK) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Cytokinetics · Health Care · ref. ETF XLV · 81 calls · price $61.62
What the company does: Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States.
📈 Cytokinetics (CYTK) stock price
$61.62+1.0% over range
Oct 14, 25low $54.76 · high $87.26Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 13 analysts
📊 JPI status : Cytokinetics is currently in ⚡ JPI Risk + n°12. Also present in past years.
🎯 CYTK price target & analyst consensus — price $61.62
The price target · all analysts combined (13 targets)
Highest target · 1 firm of 13$140+127.2%
Median target · of 13 targets$110+78.5%
Lowest target · 1 firm of 13$99+60.7%
Current price$61.62
Where these 13 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
13100%
$99 ↔ $140
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: HC Wainwright & Co. — 71% of its targets hit on this sector (248 calls tested). It aims for $140 (+127 %), call made on September 1, 2026, maturing on September 1, 2027 (43 d ago).
The 4 reliable analysts
$113+83 %
The 9 other firms
$110+79 %
How to read it: the 4 reliable firms are not filtered by optimism — 4 aim above the price, 0 below, hence their $113 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy13100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 CYTK price target all
All 81 calls, one by one, with our verdict on each firm.
→ See all 81 targets, analyst by analyst💡 The best analysts on CYTK most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in CYTK? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Cytokinetics? The JPI assistant answers using our backtest data.
📈 Cytokinetics fundamentals: valuation, margins & growth › open the full page
P/E —Net margin 0.0 %Revenue growth -57.1 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -411 %
2023
Rev −92%
2024
Rev +145%
2025
Rev +377%
🔎 Detailed analyses
✅ Historical analyst reliability on CYTK
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Citigroup ↗ | 100% | +92.0% | 4 |
| RBC Capital ↗ | 100% | +59.4% | 3 |
| Stifel ↗ | 100% | +43.3% | 2 |
| Cantor Fitzgerald ↗ | 89% | +52.0% | 9 |
| Barclays ↗ | 83% | +38.5% | 6 |
| Morgan Stanley ↗ | 71% | +44.0% | 14 |
| HC Wainwright & Co. ↗ | 70% | +20.8% | 50 |
| Goldman Sachs ↗ | 67% | +52.5% | 6 |
| B. Riley Securities ↗ | 67% | +18.3% | 3 |
| Needham ↗ | 64% | +22.7% | 28 |
See the other 9 firms
| Truist Securities ↗ | 0% | -36.9% | 4 |
| Raymond James ↗ | 0% | -36.0% | 4 |
| Leerink Swann | 50% | -14.0% | 2 |
| Piper Sandler ↗ | 50% | +13.2% | 4 |
| JP Morgan ↗ | 50% | +19.4% | 6 |
| UBS ↗ | 50% | +34.9% | 2 |
| JMP Securities | 56% | +20.1% | 16 |
| Mizuho ↗ | 57% | +19.2% | 7 |
| Oppenheimer ↗ | 60% | +10.8% | 5 |
📊 What $1,000 invested in Cytokinetics would be worth › open the full page
In short — $1,000 invested in Cytokinetics 10 years ago would be worth $8,144 today, i.e. +23%/yr on average. Best year: 2021 (+119%), worst: 2024 (-44%). Price performance, excluding dividends.
If I'd invested $1,000 in Cytokinetics
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,811 | +81% |
| 3 years ago | $1,859 | +86% |
| 5 years ago | $4,100 | +310% |
Return by year (Cytokinetics)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +34% | $1,341 (+34%) |
| 2025 | +35% | $1,811 (+81%) |
| 2024 | -44% | $1,020 (+2%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Cytokinetics
Loading news…
📋 All analyst calls on CYTK
Filtered on — · ✕ show all
RBC Capital ↗
Oct 8, 26
▲ Outperform · 🎯$113
Price at call : $62.91 — upside +80%
Today : $61.62 — upside +83%
🎯 on CYTK : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Oct 8, 27
matures : Oct 8, 27
HC Wainwright & Co. ↗
Aug 31, 26
▲ Buy · 🎯$140
Price at call : $70.91 — upside +97%
Today : $61.62 — upside +127%
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Aug 31, 27
matures : Aug 31, 27
▲ Overweight · 🎯$110
Price at call : $74.13 — upside +48%
Today : $61.62 — upside +79%
🎯 on CYTK : 100% (2 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
▲ Overweight · 🎯$103
Price at call : $74.13 — upside +39%
Today : $61.62 — upside +67%
🎯 on CYTK : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
Truist Securities ↗
Aug 10, 26
▲ Buy · 🎯$112
Price at call : $76.45 — upside +47%
Today : $61.62 — upside +82%
🎯 on CYTK : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
RBC Capital ↗
Aug 7, 26
▲ Outperform · 🎯$112
Price at call : $77.49 — upside +45%
Today : $61.62 — upside +82%
🎯 on CYTK : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Citizens
Aug 7, 26
▲ Market Outperform · 🎯$110
Price at call : $77.49 — upside +42%
Today : $61.62 — upside +79%
🎯 on CYTK : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Buy · 🎯$112
Price at call : $76.76 — upside +46%
Today : $61.62 — upside +82%
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
See the other 73 calls, newest to oldest
RBC Capital ↗
Jul 7, 26
▲ Outperform · 🎯$117
Price at call : $84.88 — upside +38%
Today : $61.62 — upside +90%
🎯 on CYTK : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
▲ Buy · 🎯$115
Price at call : $85.19 — upside +35%
Today : $61.62 — upside +87%
🎯 on CYTK : no call matured yet · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
▲ Outperform · 🎯$118
Price at call : $81.2 — upside +45%
Today : $61.62 — upside +91%
🎯 on CYTK : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
▲ Buy · 🎯$102
Price at call : $78.11 — upside +31%
Today : $61.62 — upside +66%
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Jun 17, 27
matures : Jun 17, 27
▲ Buy · 🎯$99
Price at call : $78.77 — upside +26%
Today : $61.62 — upside +61%
🎯 on CYTK : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : May 19, 27
matures : May 19, 27
▲ Overweight · 🎯$97
Price at call : $77.22 — upside +26%
Today : $61.62 — upside +57%
🎯 on CYTK : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
HC Wainwright & Co. ↗
May 11, 26
▲ Buy · 🎯$140
Price at call : $74.56 — upside +88%
Today : $61.62 — upside +127%
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
Wells Fargo ↗
May 7, 26
▲ Overweight · 🎯$105
Price at call : $76.91 — upside +37%
Today : $61.62 — upside +70%
🎯 on CYTK : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Buy · 🎯$108
Price at call : $74.29 — upside +45%
Today : $61.62 — upside +75%
🎯 on CYTK : no call matured yet · 📊 on Health : 48% · +12.3% (100 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Morgan Stanley ↗
May 6, 26
▲ Overweight · 🎯$103
Price at call : $74.29 — upside +39%
Today : $61.62 — upside +67%
🎯 on CYTK : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
RBC Capital ↗
May 6, 26
▲ Outperform · 🎯$119
Price at call : $74.29 — upside +60%
Today : $61.62 — upside +93%
🎯 on CYTK : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Buy · 🎯$102
Price at call : $74.84 — upside +36%
Today : $61.62 — upside +66%
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Wells Fargo ↗
Apr 10, 26
▲ Overweight · 🎯$95
Price at call : $66.72 — upside +42%
Today : $61.62 — upside +54%
🎯 on CYTK : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Apr 10, 27
matures : Apr 10, 27
▲ Overweight · 🎯$95
Price at call : $65.48 — upside +45%
Today : $61.62 — upside +54%
🎯 on CYTK : 100% (2 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Outperform · 🎯$100
Price at call : $62.95 — upside +59%
Today : $61.62 — upside +62%
🎯 on CYTK : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Mar 18, 27
matures : Mar 18, 27
▲ Overweight · 🎯$75
Price at call : $62.19 — upside +21%
Today : $61.62 — upside +22%
🎯 on CYTK : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Mar 17, 27
matures : Mar 17, 27
■ Neutral neutral · not a buy · 🎯$69
Price at call : $62.42 — gap to target +11%
Today : $61.62 — gap to target +12%
🎯 on CYTK : no call matured yet · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
Leerink Partners ↗
Feb 26, 26
▲ Outperform · 🎯$84
Price at call : $62.22 — upside +35%
Today : $61.62 — upside +36%
🎯 on CYTK : no call matured yet · 📊 on Health : 58.3% · +20.9% (12 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Citizens
Feb 25, 26
▲ Market Outperform · 🎯$96
Price at call : $62.89 — upside +53%
Today : $61.62 — upside +56%
🎯 on CYTK : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Buy · 🎯$85
Price at call : $62.89 — upside +35%
Today : $61.62 — upside +38%
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
RBC Capital ↗
Feb 20, 26
▲ Outperform · 🎯$101
Price at call : $67.94 — upside +49%
Today : $61.62 — upside +64%
🎯 on CYTK : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Truist Securities ↗
Feb 3, 26
▲ Buy · 🎯$92
Price at call : $64.73 — upside +42%
Today : $61.62 — upside +49%
🎯 on CYTK : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
B. Riley Securities ↗
Jan 21, 26
▲ Buy · 🎯$108
Price at call : $64.93 — upside +66%
Today : $61.62 — upside +75%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 52% · +22.0% (25 calls)
in progress (365j)
matures : Jan 21, 27
matures : Jan 21, 27
RBC Capital ↗
Jan 21, 26
▲ Outperform · 🎯$95
Price at call : $64.93 — upside +46%
Today : $61.62 — upside +54%
🎯 on CYTK : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Jan 21, 27
matures : Jan 21, 27
▲ Overweight · 🎯$74
Price at call : $63.04 — upside +17%
Today : $61.62 — upside +20%
🎯 on CYTK : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
Morgan Stanley ↗
Dec 23, 25
▲ Overweight · 🎯$71
Price at call : $64.18 — upside +11%
Today : $61.62 — upside +15%
🎯 on CYTK : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Dec 23, 26
matures : Dec 23, 26
RBC Capital ↗
Dec 22, 25
▲ Outperform · 🎯$95
Price at call : $65.6 — upside +45%
Today : $61.62 — upside +54%
🎯 on CYTK : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Dec 22, 26
matures : Dec 22, 26
▲ Overweight · 🎯$87
Price at call : $65.6 — upside +33%
Today : $61.62 — upside +41%
🎯 on CYTK : 100% (2 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Dec 22, 26
matures : Dec 22, 26
Citizens
Dec 22, 25
▲ Market Outperform · 🎯$88
Price at call : $65.6 — upside +34%
Today : $61.62 — upside +43%
🎯 on CYTK : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Dec 22, 26
matures : Dec 22, 26
▲ Buy · 🎯$84
Price at call : $65.6 — upside +28%
Today : $61.62 — upside +36%
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Dec 22, 26
matures : Dec 22, 26
HC Wainwright & Co. ↗
Dec 22, 25
▲ Buy · 🎯$136
Price at call : $65.6 — upside +107%
Today : $61.62 — upside +121%
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Dec 22, 26
matures : Dec 22, 26
Goldman Sachs ↗
Dec 19, 25
▲ Buy · 🎯$95
Price at call : $65.6 — upside +45%
Today : $61.62 — upside +54%
🎯 on CYTK : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Dec 19, 26
matures : Dec 19, 26
▲ Buy · 🎯$72
Price at call : $63.35 — upside +14%
Today : $61.62 — upside +17%
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Dec 12, 26
matures : Dec 12, 26
RBC Capital ↗
Nov 11, 25
▲ Outperform · 🎯$87
Price at call : $65.94 — upside +32%
Today : $61.62 — upside +41%
🎯 on CYTK : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Nov 11, 26
matures : Nov 11, 26
B. Riley Securities ↗
Nov 10, 25
▲ Buy · 🎯$90
Price at call : $66.5 — upside +35%
Today : $61.62 — upside +46%
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 52% · +22.0% (25 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
▲ Overweight · 🎯$82
Price at call : $60.64 — upside +35%
Today : $61.62 — upside +33%
Expected +35% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on CYTK : 100% (2 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
+1.2%
stock +1% · XLV +16%
matured Oct 6, 26
B of A Securities ↗
Oct 2, 25
■ Neutral neutral · not a buy · 🎯$56
Price at call : $56.97 — gap to target -2%
Today : $61.62 — gap to target -9%
🎯 on CYTK : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
HC Wainwright & Co. ↗
Sep 29, 25
▲ Buy · 🎯$120
Price at call : $54.96 — upside +118%
Today : $61.62 — upside +95%
Expected +118% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+19.9%
stock +20% · XLV +21%
matured Sep 29, 26
B. Riley Securities ↗
Sep 22, 25
▲ Buy · 🎯$80
Price at call : $48.55 — upside +65%
Today : $61.62 — upside +30%
Expected +65% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 52% · +22.0% (25 calls)
+35.5%
stock +36% · XLV +23%
matured Sep 22, 26
HC Wainwright & Co. ↗
Sep 22, 25
▲ Buy · 🎯$120
Price at call : $48.25 — upside +149%
Today : $61.62 — upside +95%
Expected +149% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+40.1%
stock +40% · XLV +24%
matured Sep 22, 26
▲ Overweight · 🎯$71
Price at call : $49.75 — upside +43%
Today : $61.62 — upside +15%
Expected +43% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (2 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
+46.2%
stock +46% · XLV +25%
matured Sep 3, 26
Evercore ISI Group ↗
Sep 3, 25
▲ Outperform · 🎯$80
Price at call : $49.75 — upside +61%
Today : $61.62 — upside +30%
Expected +61% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (1 call matured) · 📊 on Health : 39.1% · -4.9% (46 calls)
+46.2%
stock +46% · XLV +25%
matured Sep 3, 26
▲ Buy · 🎯$72
Price at call : $49.62 — upside +45%
Today : $61.62 — upside +17%
Expected +45% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+45.0%
stock +45% · XLV +26%
matured Sep 2, 26
▲ Buy · 🎯$72
Price at call : $30 — upside +140%
Today : $61.62 — upside +17%
Expected +140% · Actual +162% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+162.1%
stock +162% · XLV +14%
matured May 14, 26
▲ Buy · 🎯$72
Price at call : $37.35 — upside +93%
Today : $61.62 — upside +17%
Expected +93% · Actual +77% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+76.8%
stock +77% · XLV +4%
matured May 2, 26
HC Wainwright & Co. ↗
Apr 21, 25
▲ Buy · 🎯$120
Price at call : $37.81 — upside +217%
Today : $61.62 — upside +95%
Expected +217% · Actual +75% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+75.2%
stock +75% · XLV +8%
matured Apr 21, 26
HC Wainwright & Co. ↗
Apr 15, 25
▲ Buy · 🎯$120
Price at call : $39.15 — upside +207%
Today : $61.62 — upside +95%
Expected +207% · Actual +67% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+67.1%
stock +67% · XLV +8%
matured Apr 15, 26
▲ Buy · 🎯$72
Price at call : $34.57 — upside +108%
Today : $61.62 — upside +17%
Expected +108% · Actual +90% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+90.3%
stock +90% · XLV +13%
matured Apr 8, 26
HC Wainwright & Co. ↗
Apr 4, 25
▲ Buy · 🎯$120
Price at call : $37.36 — upside +221%
Today : $61.62 — upside +95%
Expected +221% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+73.8%
stock +74% · XLV +8%
matured Apr 4, 26
HC Wainwright & Co. ↗
Feb 28, 25
▲ Buy · 🎯$120
Price at call : $46 — upside +161%
Today : $61.62 — upside +95%
Expected +161% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+33.5%
stock +34% · XLV +6%
matured Feb 28, 26
▲ Buy · 🎯$72
Price at call : $42.76 — upside +68%
Today : $61.62 — upside +17%
Expected +68% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+48.2%
stock +48% · XLV +7%
matured Feb 6, 26
HC Wainwright & Co. ↗
Jan 22, 25
▲ Buy · 🎯$120
Price at call : $46.82 — upside +156%
Today : $61.62 — upside +95%
Expected +156% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+38.7%
stock +39% · XLV +11%
matured Jan 22, 26
HC Wainwright & Co. ↗
Jan 21, 25
▲ Buy · 🎯$120
Price at call : $46.82 — upside +156%
Today : $61.62 — upside +95%
Expected +156% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+38.7%
stock +39% · XLV +11%
matured Jan 21, 26
HC Wainwright & Co. ↗
Jan 14, 25
▲ Buy · 🎯$120
Price at call : $45.23 — upside +165%
Today : $61.62 — upside +95%
Expected +165% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+42.8%
stock +43% · XLV +13%
matured Jan 14, 26
HC Wainwright & Co. ↗
Jan 10, 25
▲ Buy
Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+38.6%
stock +39% · XLV +13%
matured Jan 10, 26
HC Wainwright & Co. ↗
Dec 23, 24
▲ Buy · 🎯$120
Price at call : $48.95 — upside +145%
Today : $61.62 — upside +95%
Expected +145% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+29.3%
stock +29% · XLV +12%
matured Dec 23, 25
HC Wainwright & Co. ↗
Dec 20, 24
▲ Buy · 🎯$120
Price at call : $48.95 — upside +145%
Today : $61.62 — upside +95%
Expected +145% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+34.0%
stock +34% · XLV +12%
matured Dec 20, 25
▲ Buy · 🎯$72
Price at call : $51.51 — upside +40%
Today : $61.62 — upside +17%
Expected +40% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+25.5%
stock +26% · XLV +6%
matured Dec 2, 25
▲ Buy · 🎯$72
Price at call : $49.86 — upside +44%
Today : $61.62 — upside +17%
Expected +44% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+27.4%
stock +27% · XLV +6%
matured Nov 20, 25
Cantor Fitzgerald ↗
Oct 18, 24
▲ Overweight
Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on CYTK : 89% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+8.0%
stock +8% · XLV -5%
matured Oct 18, 25
▲ Buy · 🎯$72
Price at call : $54.53 — upside +32%
Today : $61.62 — upside +17%
Expected +32% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+7.2%
stock +7% · XLV -6%
matured Oct 17, 25
Cantor Fitzgerald ↗
Sep 9, 24
▲ Overweight
Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on CYTK : 89% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-4.0%
stock -4% · XLV -12%
matured Sep 9, 25
▲ Buy · 🎯$72
Price at call : $54.56 — upside +32%
Today : $61.62 — upside +17%
Expected +32% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-8.4%
stock -8% · XLV -13%
matured Sep 3, 25
▲ Buy · 🎯$72
Price at call : $56.18 — upside +28%
Today : $61.62 — upside +17%
Expected +28% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-40.8%
stock -41% · XLV -13%
matured Aug 9, 25
▲ Buy · 🎯$72
Price at call : $48.98 — upside +47%
Today : $61.62 — upside +17%
Expected +47% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-37.6%
stock -38% · XLV -10%
matured May 23, 25
▲ Buy · 🎯$108
Price at call : $59.36 — upside +82%
Today : $61.62 — upside +75%
Expected +82% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on CYTK : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-49.5%
stock -49% · XLV -11%
matured May 14, 25
Cantor Fitzgerald ↗
Oct 9, 23
▲ Overweight · 🎯$65
Price at call : $34.87 — upside +86%
Today : $61.62 — upside +5%
Expected +86% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 89% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+56.0%
stock +56% · XLV +17%
matured Oct 8, 24
Cantor Fitzgerald ↗
Aug 22, 23
▲ Overweight · 🎯$59
Price at call : $33.05 — upside +79%
Today : $61.62 — upside -4%
Expected +79% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 89% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+70.2%
stock +70% · XLV +16%
matured Aug 21, 24
Cantor Fitzgerald ↗
Apr 3, 23
▲ Overweight · 🎯$59
Price at call : $36.33 — upside +62%
Today : $61.62 — upside -4%
Expected +62% · Actual +95% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 89% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+95.2%
stock +95% · XLV +10%
matured Apr 2, 24
Cantor Fitzgerald ↗
Mar 7, 23
▲ Overweight · 🎯$61
Price at call : $40.11 — upside +52%
Today : $61.62 — upside -1%
Expected +52% · Actual +67% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 89% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+66.7%
stock +67% · XLV +15%
matured Mar 6, 24
Cantor Fitzgerald ↗
Apr 17, 20
▲ Overweight · 🎯$23
Price at call : $15.24 — upside +51%
Today : $61.62 — upside -63%
Expected +51% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 89% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+62.3%
stock +62% · XLV +21%
matured Apr 17, 21
Cantor Fitzgerald ↗
Sep 6, 19
▲ Overweight · 🎯$20
Price at call : $14.09 — upside +42%
Today : $61.62 — upside -68%
Expected +42% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 89% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+59.7%
stock +60% · XLV +14%
matured Sep 5, 20
Cantor Fitzgerald ↗
Sep 21, 18
▲ Overweight · 🎯$14
Price at call : $8.5 — upside +65%
Today : $61.62 — upside -77%
Expected +65% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on CYTK : 89% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+54.2%
stock +54% · XLV -3%
matured Sep 21, 19
Frequently asked questions
Should I buy Cytokinetics stock?
This isn't buy advice. For Cytokinetics, the analyst consensus is "Buy", with an average price target of $110 (+79% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Cytokinetics). We show the numbers — you decide.
Is it too late to buy Cytokinetics? How high can it go?
The most bullish analyst target on Cytokinetics is $140 (+127% above today's price); the average is $110. That's the upside they see. Check how reliable those analysts have actually been on Cytokinetics on our site before trusting it.
Is Cytokinetics still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 19 analysts have a real record on Cytokinetics, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Cytokinetics? The case for and against
The arguments for and against, one by one, from the numbers: why invest in CYTK (and why hesitate).
What has Cytokinetics's past performance been?
Historical returns and a "how much if I had invested" calculator: CYTK performance & returns.
What is the best month to buy CYTK?
The 12 months ranked by the stock's past returns: best & worst month to buy CYTK.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX